Neuronetics Statistics
Total Valuation
Neuronetics has a market cap or net worth of $104.61 million. The enterprise value is $171.63 million.
Important Dates
The next estimated earnings date is Tuesday, May 5, 2026, before market open.
| Earnings Date | May 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Neuronetics has 69.28 million shares outstanding. The number of shares has increased by 107.82% in one year.
| Current Share Class | 69.28M |
| Shares Outstanding | 69.28M |
| Shares Change (YoY) | +107.82% |
| Shares Change (QoQ) | +2.15% |
| Owned by Insiders (%) | 22.96% |
| Owned by Institutions (%) | 34.56% |
| Float | 27.27M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.73 |
| Forward PS | 0.66 |
| PB Ratio | 4.87 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.15 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.02, with a Debt / Equity ratio of 3.44.
| Current Ratio | 2.02 |
| Quick Ratio | 1.47 |
| Debt / Equity | 3.44 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3.69 |
Financial Efficiency
Return on equity (ROE) is -134.86% and return on invested capital (ROIC) is -16.80%.
| Return on Equity (ROE) | -134.86% |
| Return on Assets (ROA) | -13.73% |
| Return on Invested Capital (ROIC) | -16.80% |
| Return on Capital Employed (ROCE) | -27.95% |
| Weighted Average Cost of Capital (WACC) | 8.28% |
| Revenue Per Employee | $226,682 |
| Profits Per Employee | -$59,267 |
| Employee Count | 658 |
| Asset Turnover | 1.06 |
| Inventory Turnover | 17.83 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -55.49% in the last 52 weeks. The beta is 0.87, so Neuronetics's price volatility has been lower than the market average.
| Beta (5Y) | 0.87 |
| 52-Week Price Change | -55.49% |
| 50-Day Moving Average | 1.49 |
| 200-Day Moving Average | 2.43 |
| Relative Strength Index (RSI) | 55.10 |
| Average Volume (20 Days) | 2,326,884 |
Short Selling Information
The latest short interest is 9.36 million, so 13.51% of the outstanding shares have been sold short.
| Short Interest | 9.36M |
| Short Previous Month | 10.26M |
| Short % of Shares Out | 13.51% |
| Short % of Float | 34.31% |
| Short Ratio (days to cover) | 8.87 |
Income Statement
In the last 12 months, Neuronetics had revenue of $149.16 million and -$39.00 million in losses. Loss per share was -$0.59.
| Revenue | 149.16M |
| Gross Profit | 72.71M |
| Operating Income | -31.04M |
| Pretax Income | -39.14M |
| Net Income | -39.00M |
| EBITDA | -27.63M |
| EBIT | -31.04M |
| Loss Per Share | -$0.59 |
Full Income StatementBalance Sheet
The company has $28.13 million in cash and $90.30 million in debt, with a net cash position of -$62.17 million or -$0.90 per share.
| Cash & Cash Equivalents | 28.13M |
| Total Debt | 90.30M |
| Net Cash | -62.17M |
| Net Cash Per Share | -$0.90 |
| Equity (Book Value) | 26.24M |
| Book Value Per Share | 0.32 |
| Working Capital | 31.03M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$20.37 million and capital expenditures -$801,000, giving a free cash flow of -$21.18 million.
| Operating Cash Flow | -20.37M |
| Capital Expenditures | -801,000 |
| Depreciation & Amortization | 3.41M |
| Net Borrowing | 9.79M |
| Free Cash Flow | -21.18M |
| FCF Per Share | -$0.31 |
Full Cash Flow StatementMargins
Gross margin is 48.75%, with operating and profit margins of -20.81% and -26.15%.
| Gross Margin | 48.75% |
| Operating Margin | -20.81% |
| Pretax Margin | -26.24% |
| Profit Margin | -26.15% |
| EBITDA Margin | -18.52% |
| EBIT Margin | -20.81% |
| FCF Margin | n/a |
Dividends & Yields
Neuronetics does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -107.82% |
| Shareholder Yield | -107.82% |
| Earnings Yield | -35.63% |
| FCF Yield | -19.35% |
Analyst Forecast
The average price target for Neuronetics is $3.00, which is 98.68% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $3.00 |
| Price Target Difference | 98.68% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | 12.89% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Neuronetics has an Altman Z-Score of -2.83 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.83 |
| Piotroski F-Score | 3 |
